geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Captopril in the treatment of chronic cardiac insufficiency


, : Captopril in the treatment of chronic cardiac insufficiency. Vrachebnoe Delo (8): 43-46

Patients (11), including 5 patients with ischemic heart disease and 6 patients with rheumatic heart disease were examined. Short-term treatment of patients with severe chronic cardiac insufficiency by small doses of captopril had favorable cardiovascular, hormonal and renal effects. This treatment reduced vasoconstriction, secondary aldosteronism, and renal retention of Na and water. It increased cardiac output and improved systemic and regional circulation. According to the data from the literature, positive changes are retained and even intensified in the course of long-term (weeks, months) treatment with captopril. The data obtained make it possible to recommend the use of this drug as part of multimodality therapy for patients with severe chronic cardiac insufficiency.

US$29.90


Other references

Keykhah, M.M.hdi; Storella, R.J.; Shi, Y.; Rosenberg, H., 1993: Low dose vecuronium blocks hyperthermic contracture and hypotension in rats. Anesthesiology (Hagerstown) 79(3A): A916

Kwon, I.Gyu.; Son, Y-Gil.; Ryu, S.Wan., 2016: Novel Intracorporeal Esophagojejunostomy Using Linear Staplers During Laparoscopic Total Gastrectomy: π-Shaped Esophagojejunostomy, 3-in-1 Technique. Journal of the American College of Surgeons 223(3): E25-E29

Haener, M.; Dosman, D.A.amowicz, W.; Boxall, P., 2001: Can stated preference methods be used to value attributes of subsistence hunting by aboriginal peoples? A case study in northern Saskatchewan. American journal of agricultural economics3(5): 1334-1340

Williams, EE., 1988: A new look at the Iguania. Unknown

Schwickert, A.; Weghake, E.; Brüggemann, K.; Engbers, A.; Brinkmann, B.F.; Kemper, Börn.; Seggewiß, J.; Stock, C.; Ebnet, K.; Kiesel, L.; Riethmüller, C.; Götte, M., 2016: microRNA miR-142-3p Inhibits Breast Cancer Cell Invasiveness by Synchronous Targeting of WASL, Integrin Alpha V, and Additional Cytoskeletal Elements. MicroRNAs (miRNAs, micro ribonucleic acids) are pivotal post-transcriptional regulators of gene expression. These endogenous small non-coding RNAs play significant roles in tumorigenesis and tumor progression. miR-142-3p expression is dysregulated...

Renedo, M.A.; Fernandez, N.; Sanchez Crespo, M., 2001: FcgammaRIIA expressed in epithelial cells activates the mitogen-activated protein kinase cascade Relevance for therapeutics. Inflammation Research 50(Supplement 3): S215, September

Rassoulzadegan, M.; Akyurtlakl, N., 2002: An investigation on the toxic effects of malathion (organophosphate insecticide) on the Daphnia magna Straus, 1820 (Crustacea, Cladocera). The toxic effects of technical grade (95%) malathion and commercial (25%) malathion were investigated on young (<=24 h old) D. magna in static acute toxicity tests (24 and 48 hours). The culture of D. magna and toxicity tests were performed at...

Drake, R.E.; Morse, G.; Brunette, M.F.; Torrey, W.C., 2004: Evolving U.S. service model for patients with severe mental illness and co-occurring substance use disorder. Co-occurring severe mental illness and substance use disorder has been recognized as a common problem in the U.S. since the early 1980s (1-3). For these individuals with co-occurring disorders, research demonstrates the effectiveness of various fo...

Cirelli, C.; Tononi, G., 2004: Uncoupling proteins and sleep deprivation. In both humans and animals sleep deprivation (SD) produces an increase in food intake and in energy expenditure (EE). The increase in EE is a core element of the SD syndrome and, in rats, is negatively correlated with survival rate. However, the m...

Chen, S.; Chrusciel, R.A.; Nakanishi, H.; Raktabutr, A.; Johnson, M.E.; Sato, A.; Weiner, D.; Hoxie, J.; Saragovi, H.U.; Greene, M.I., 1992: Design and synthesis of a CD4 beta-turn mimetic that inhibits human immunodeficiency virus envelope glycoprotein gp120 binding and infection of human lymphocytes. Poor bioavailability, rapid degradation, antigenicity, and high cost often limit the use of proteinaceous pharmaceuticals. One goal of structural biochemistry is the reduction of complex molecules to small functional units that are amenable to hig...